189 related articles for article (PubMed ID: 30383632)
1. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
Sun Y; Jia L; Yang Z; Chen W
Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
[TBL] [Abstract][Full Text] [Related]
3. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Mariani G; Konkle BA; Ingerslev J
Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
[TBL] [Abstract][Full Text] [Related]
4. Surgery in patients with congenital factor VII deficiency - a single center study.
Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A
Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
[No Abstract] [Full Text] [Related]
6. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G
Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009
[TBL] [Abstract][Full Text] [Related]
7. Is prophylaxis required for delivery in women with factor VII deficiency?
Baumann Kreuziger LM; Morton CT; Reding MT
Haemophilia; 2013 Nov; 19(6):827-32. PubMed ID: 23607277
[TBL] [Abstract][Full Text] [Related]
8. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
[TBL] [Abstract][Full Text] [Related]
10. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
Lapecorella M; Mariani G;
Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.
Shams M; Dorgalaleh A; Safarian N; Emami AH; Zaker F; Tabibian S; Managhchi MR; Faranoush M; Tabatabaei T; Satari S; Rezvani MR
Blood Coagul Fibrinolysis; 2019 Jan; 30(1):24-28. PubMed ID: 30585836
[TBL] [Abstract][Full Text] [Related]
12. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
[TBL] [Abstract][Full Text] [Related]
13. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Karimi M
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
[TBL] [Abstract][Full Text] [Related]
14. Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia-A Case Series and Review of the Literature.
Krzyżanowski A; Gęca T; Sokołowska B; Kwiatek M; Miturski A; Stupak A; Terlecki P; Paluszkiewicz P; Kwaśniewska A
Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078653
[No Abstract] [Full Text] [Related]
15. Perioperative management for patient with congenital factor VII deficiency who underwent laparoscopic cholecystectomy: Case report.
Yoshimura T; Hayami S; Kawai M; Okada KI; Ueno M; Yamaue H
Int J Surg Case Rep; 2022 Mar; 92():106892. PubMed ID: 35278984
[TBL] [Abstract][Full Text] [Related]
16. Patient with congenital factor VII deficiency undergoing brain tumor neurosurgery successfully treated with recombinant factor VIIa and fresh frozen plasma: A case report and literature review.
Huang C; Yu Y; Zhai N; Mo W; Lin F
Medicine (Baltimore); 2023 Dec; 102(52):e36694. PubMed ID: 38206717
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
Wong WY; Huang WC; Miller R; McGinty K; Whisnant JK
Haemophilia; 2000 Jan; 6(1):50-4. PubMed ID: 10632743
[TBL] [Abstract][Full Text] [Related]
19. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
20. Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment.
Kuperman AA; Barg AA; Fruchtman Y; Shaoul E; Rosenberg N; Kenet G; Livnat T
Blood Cells Mol Dis; 2017 Sep; 67():86-90. PubMed ID: 28038846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
